Search Results - "Karmiris, K"

Refine Results
  1. 1
  2. 2

    Editorial: monitoring vedolizumab trough serum concentration in inflammatory bowel disease—following the fate of anti‐TNF‐alpha agents? by Fragaki, M., Karmiris, K.

    Published in Alimentary pharmacology & therapeutics (01-05-2018)
    “…Linked Content This article is linked to Yacoub et al paper. To view this article visit https://doi.org/10.1111/apt.14548…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Efficacy of bispectral index monitoring as an adjunct to propofol deep sedation for ERCP: a randomized controlled trial by Paspatis, G A, Chainaki, I, Manolaraki, M M, Vardas, E, Theodoropoulou, A, Tribonias, G, Konstantinidis, K, Karmiris, K, Chlouverakis, G

    Published in Endoscopy (01-12-2009)
    “…We sought to determine whether bispectral index (BIS) monitoring is a useful adjunct to the administration of propofol titrated to deep sedation, as measured…”
    Get more information
    Journal Article
  7. 7

    Comparison of standard vs high-definition, wide-angle colonoscopy for polyp detection: a randomized controlled trial by Tribonias, G., Theodoropoulou, A., Konstantinidis, K., Vardas, E., Karmiris, K., Chroniaris, N., Chlouverakis, G., Paspatis, G. A.

    Published in Colorectal disease (01-10-2010)
    “…Aim  We sought to compare the performance of colonoscopy using a high‐definition, wide‐angle endoscope vs a standard colonoscope for the detection of polyps…”
    Get full text
    Journal Article
  8. 8

    Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel disease by Koutroubakis, I. E., Xidakis, C., Karmiris, K., Sfiridaki, A., Kandidaki, E., Kouroumalis, E. A.

    Published in European journal of clinical investigation (01-02-2006)
    “…Background  Angiogenesis has been suggested to play an important role in inflammatory bowel disease (IBD). The aim of the study was to evaluate the serum…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    P768 The prevalence and risk factors for malignancies in patients with inflammatory bowel disease in Crete : a case control study by Foteinogiannopoulou, K, Nicolaou, P, Mala, A, Theodoraki, E, Orfanoudaki, E, Theodoropoulou, A, Karmiris, K, Koutroubakis, I

    Published in Journal of Crohn's and colitis (30-01-2023)
    “…Abstract Background There is evidence that about 30% of the patients with inflammatory bowel disease (IBD) develop malignancies whichconstitute the second…”
    Get full text
    Journal Article
  12. 12
  13. 13

    P531 Tuberculin skin test conversion rate in inflammatory bowel disease patients receiving anti-TNFα agents by Fragaki, M, Paspatis, G, Karmiris, K

    Published in Journal of Crohn's and colitis (16-01-2018)
    “…Abstract Background Anti-TNFα therapy increases the risk of tuberculosis (TB) (re)-activation in inflammatory bowel disease (IBD) patients. Purified protein…”
    Get full text
    Journal Article
  14. 14

    P138 The use of video capsule endoscopy (vce) in patinets with a new diagnosis of Crohn's disease: the experience of one center by Nicolaou, P, Theodoropoulou, A, Psistakis, A, Arna, D, Velegraki, M, Fragkaki, M, Karmiris, K, Vardas, E, Paspatis, G

    Published in Journal of Crohn's and colitis (30-01-2023)
    “…Abstract Background Crohn’s disease can involve any segment of the gastrointestinal tract, with terminal ileum being the most common affected part. The…”
    Get full text
    Journal Article
  15. 15

    P843 Post-vaccination kinetics of antibodies against hepatitis B surface antigen in inflammatory bowel disease patients: a single-centre cohort study by Dimas, I, Voudoukis, E, Paspatis, G, Karmiris, K

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background Inflammatory bowel disease (IBD) patients are susceptible to post-vaccination immunity loss long-term. No data exist regarding the kinetics…”
    Get full text
    Journal Article
  16. 16

    P833 Efficacy of vaccination against hepatitis A in inflammatory bowel disease patients: a single-centre cohort study by Dimas, I, Voudoukis, E, Paspatis, G, Karmiris, K

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background Inflammatory bowel disease (IBD) patients are vulnerable to viral infections. Cases of hepatitis A infection with a fatal outcome in…”
    Get full text
    Journal Article
  17. 17

    ECCO Topical Review: Refractory Inflammatory Bowel Disease by Raine, Tim, Verstockt, Bram, Kopylov, Uri, Karmiris, Konstantinos, Goldberg, Rimma, Atreya, Raja, Burisch, Johan, Burke, John, Ellul, Pierre, Hedin, Charlotte, Holubar, Stefan D, Katsanos, Konstantinos, Lobaton, Triana, Schmidt, Carsten, Cullen, Garret

    Published in Journal of Crohn's & colitis (07-10-2021)
    “…Abstract Inflammatory bowel disease is a chronic disease with variable degrees of extent, severity, and activity. A proportion of patients will have disease…”
    Get full text
    Journal Article Conference Proceeding
  18. 18
  19. 19

    P245 Pulmonary function tests in asymptomatic patients with inflammatory bowel disease: preliminary results of a single-centre cohort study by Fragaki, M, Pasparaki, E, Bibaki, E, Kounalakis, G, Ferdoutsis, E, Paspatis, G, Meletis, G, Karmiris, K

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background Pulmonary dysfunction is frequently underestimated in inflammatory bowel disease (IBD) patients. The aim of this study was to investigate…”
    Get full text
    Journal Article
  20. 20

    P750 Association between the use of antihypertensive agents and disease severity in patients with inflammatory bowel disease by Mantaka, A, Tsoukali, E, Fragaki, M, Karmiris, K, Viazis, N, Mantzaris, G, Koutroubakis, I

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background Accumulating evidence suggests the implication of angiotensin II in the pathogenesis of inflammatory bowel diseases (IBD) via its role as…”
    Get full text
    Journal Article